|
271 Companies |
|
374 Products |
|
374 Products |
|
160 Mechanisms of Action |
|
34 Trials |
|
5514 News |
|
| «12...7879808182838485868788...110111» |
- Enrollment open: Role of Anti Mullerian Hormone for Ovarian Reserve Determination of Preoperative and Postoperative Endometrioma Patients (clinicaltrials.gov) - Nov 11, 2013
P=N/A, N=50, Recruiting, Sponsor: Kanuni Sultan Suleyman Training and Research
Not yet recruiting --> Recruiting
- Enrollment open, Biopsy: EndoBx-IVF: Effect of Endometrial Biopsy on in Vitro Fertilization Pregnancy Rates - a Multicenter Study (clinicaltrials.gov) - Nov 11, 2013
P=N/A, N=332, Recruiting, Sponsor: Jon Havelock
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- ethinyl estradiol/levonorgestrel / Generic mfg.
Trial termination: Pituitary Down-regulation Before IVF for Women With Endometriosis (clinicaltrials.gov) - Nov 10, 2013
P4, N=5, Terminated, Sponsor: University of Oxford
Not yet recruiting --> Recruiting Enrolling by invitation --> Terminated; Unable to recruit sufficient participants
- ethinyl estradiol/levonorgestrel / Generic mfg.
Enrollment change: Pituitary Down-regulation Before IVF for Women With Endometriosis (clinicaltrials.gov) - Nov 10, 2013
P4, N=5, Terminated, Sponsor: University of Oxford
Enrolling by invitation --> Terminated; Unable to recruit sufficient participants N=100 --> 5
- ||| Biomarker, Enrollment open, Biomarker assay: New Biomarkers Evaluating Ovarian Cancer (clinicaltrials.gov) - Nov 7, 2013
P=N/A, N=500, Recruiting, Sponsor: Fujirebio Diagnostics, Inc.
N=100 --> 5 Not yet recruiting --> Recruiting
- cisplatin / Generic mfg., gemcitabine / Generic mfg.
Enrollment change, Metastases: Gemcitabine and Cisplatin for Advanced or Recurrent Endometrial Cancer (clinicaltrials.gov) - Nov 7, 2013
P2, N=21, Completed, Sponsor: M.D. Anderson Cancer Center
Not yet recruiting --> Recruiting N=35 --> 21
- cisplatin / Generic mfg., gemcitabine / Generic mfg.
Trial completion, Metastases: Gemcitabine and Cisplatin for Advanced or Recurrent Endometrial Cancer (clinicaltrials.gov) - Nov 7, 2013
P2, N=21, Completed, Sponsor: M.D. Anderson Cancer Center
N=35 --> 21 Active, not recruiting --> Completed
- Ovidrel (choriogonadotropin alfa) / EMD Serono
New P4 trial: The Effect of a Dual Trigger on Intracytoplasmic Sperm Injection (ICSI) Reproductive Outcomes (clinicaltrials.gov) - Nov 6, 2013
P4, N=400, Terminated, Sponsor: Antalya IVF
- | cabergoline / Generic mfg.
Enrollment open: Cabergoline and Coasting to Prevent OHSS (clinicaltrials.gov) - Nov 6, 2013
P3, N=200, Recruiting, Sponsor: Cairo University
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- Trial completion: Obstetric Outcomes in Women With PCOS (clinicaltrials.gov) - Nov 5, 2013
P=N/A, N=1248, Completed, Sponsor: Odense University Hospital
Not yet recruiting --> Recruiting Not yet recruiting --> Completed
- Trial completion: The Association of Ferrtin and Homocysteine Etc. With RI and MS in Polycystic Ovary Syndrome (PCOS) (clinicaltrials.gov) - Nov 5, 2013
P=N/A, N=539, Completed, Sponsor: Taipei Medical University WanFang Hospital
Not yet recruiting --> Completed Recruiting --> Completed
- |||| sevoflurane / Generic mfg.
Trial completion, Surgery: Recovery Following Desflurane Versus Sevoflurane for Outpatient Urologic Surgery in Elderly Females (clinicaltrials.gov) - Nov 5, 2013
P4, N=57, Completed, Sponsor: Hahnemann University Hospital
Recruiting --> Completed Recruiting --> Completed
- Estring (estradiol) / Pfizer
Trial completion: E-String: Vaginal Testosterone Cream vs ESTRING for Vaginal Dryness or Decreased Libido in Early Stage Breast Cancer Patients (clinicaltrials.gov) - Nov 5, 2013
P2, N=76, Completed, Sponsor: University of California, San Francisco
Recruiting --> Completed Active, not recruiting --> Completed
- Avastin (bevacizumab) / Roche
Enrollment open: Observation of Bevacizumab Plus Front-line Chemotherapy in Patients With Ovarian Cancer (clinicaltrials.gov) - Nov 5, 2013
P=N/A, N=200, Recruiting, Sponsor: Hellenic Oncology Research Group
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- Trial termination, HEOR: The Effects Of Yoga On Quality Of Life Among A Population Of Ovarian/ Fallopian Tube/ Primary Peritoneal Cancer Patients Receiving Chemotherapy: A Feasibility Study (clinicaltrials.gov) - Nov 4, 2013
P=N/A, N=25, Terminated, Sponsor: Northwestern University
Not yet recruiting --> Recruiting Recruiting --> Terminated; The investigators concluded that it is not feasible due to the lack of participation and difficulty in recruiting patients.
- Enrollment change, HEOR: The Effects Of Yoga On Quality Of Life Among A Population Of Ovarian/ Fallopian Tube/ Primary Peritoneal Cancer Patients Receiving Chemotherapy: A Feasibility Study (clinicaltrials.gov) - Nov 4, 2013
P=N/A, N=25, Terminated, Sponsor: Northwestern University
Recruiting --> Terminated; The investigators concluded that it is not feasible due to the lack of participation and difficulty in recruiting patients. N=48 --> 25
- ||||| Visanne (dienogest) / Mochida, Bayer
Enrollment closed: Comparative Study of BAY86-5300 With an Extended Flexible Regimen for Endometriosis (clinicaltrials.gov) - Nov 4, 2013
P3, N=312, Active, not recruiting, Sponsor: Bayer
N=48 --> 25 Recruiting --> Active, not recruiting
- Avastin (bevacizumab) / Roche
Trial completion: Study of Gemcitabine/Carboplatin/Bevacizumab to Treat Ovarian, Fallopian Tube or Primary Peritoneal Cancer (clinicaltrials.gov) - Nov 4, 2013
P2, N=45, Completed, Sponsor: Ohio State University Comprehensive Cancer Center
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- Enrollment change: Effect of Low-frequency Electroacupuncture (EA) on Polycystic Ovary Syndrome (clinicaltrials.gov) - Nov 3, 2013
P=N/A, N=54, Recruiting, Sponsor: Huazhong University of Science and Technology
Active, not recruiting --> Completed N=72 --> 54
- Enrollment change: Obesity and Clinical Presentation of Hyperandrogenism (clinicaltrials.gov) - Nov 3, 2013
P=N/A, N=46, Completed, Sponsor: Taipei Medical University WanFang Hospital
N=72 --> 54 N=100 --> 46
- ||| ethinyl estradiol/levonorgestrel / Generic mfg., naproxen / Generic mfg.
Enrollment closed, HEOR: iTOM: Medical Therapy Versus Radiofrequency Endometrial Ablation in the Initial Treatment of Menorrhagia (clinicaltrials.gov) - Nov 3, 2013
P4, N=120, Active, not recruiting, Sponsor: Abimbola Famuyide
N=100 --> 46 Recruiting --> Active, not recruiting
- Enrollment open: Microfinance and Health Intervention Trial for Youth in Dar es Salaam, Tanzania (clinicaltrials.gov) - Oct 31, 2013
P=N/A, N=2623, Recruiting, Sponsor: University of North Carolina, Chapel Hill
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- ||||| Trial initiation date, Monotherapy, Metastases: A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer (clinicaltrials.gov) - Oct 31, 2013
P3, N=670, Recruiting, Sponsor: Janssen Research & Development, LLC
Not yet recruiting --> Recruiting Initiation date: Jun 2013 --> Oct 2013
- || cabergoline / Generic mfg.
New P3 trial: Cabergoline and Coasting to Prevent OHSS (clinicaltrials.gov) - Oct 30, 2013
P3, N=200, Recruiting, Sponsor: Cairo University
- Enrollment closed, Preclinical: RCT on the Effect of Endometrial Injury on Ongoing Pregnancy Rate in Subfertile Women Undergoing IVF (clinicaltrials.gov) - Oct 30, 2013
P=N/A, N=300, Active, not recruiting, Sponsor: The University of Hong Kong
Initiation date: Jun 2013 --> Oct 2013 Not yet recruiting --> Active, not recruiting
- Trial completion: Topical Metronidazole and Miconazole Co-formulated Vaginal Suppositories for Preventing Vaginal Infections in HIV-seronegative Women (clinicaltrials.gov) - Oct 30, 2013
P2, N=234, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting --> Active, not recruiting Active, not recruiting --> Completed
- Enrollment open: Screening for Endometrial Abnormalities in Overweight and Obese Women (clinicaltrials.gov) - Oct 29, 2013
P=N/A, N=300, Recruiting, Sponsor: St. Luke's-Roosevelt Hospital Center
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- ganitumab (AMG 479) / Takeda, ImmunityBio
Trial completion: Study of AMG 479 as Second Line Therapy in Patients With Recurrent Platinum-sensitive Ovarian Cancer (clinicaltrials.gov) - Oct 29, 2013
P2, N=61, Completed, Sponsor: Cancer International Research Group
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- Enrollment closed, Preclinical: inSIGHT: SIGnificance of Routine Hysteroscopy Prior to a First 'in Vitro Fertilization'(IVF) Treatment Cycle (clinicaltrials.gov) - Oct 28, 2013
P4, N=738, Active, not recruiting, Sponsor: UMC Utrecht
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- | Yselty (linzagolix) / Kissei, Theramex, Syneos Health
Trial completion: A Randomized Open Label Study of KLH-2109 in Patients With Endometriosis(1) (clinicaltrials.gov) - Oct 28, 2013
P2, N=20, Completed, Sponsor: Kissei Pharmaceutical Co., Ltd.
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- | Fotivda (tivozanib) / Kyowa Kirin, Jazz, LG Chem
New P2 trial: Tivozanib As Maintenance Therapy In GYN (clinicaltrials.gov) - Oct 28, 2013
P2, N=60, Recruiting, Sponsor: Dana-Farber Cancer Institute
- |||||| Bravelle (urofollitropin) / Ferring
Enrollment open, Head-to-Head: Evaluation of Efficacy and Safety of Highly Purified Urofollitropin in Chinese Females Undergoing an Assisted Reproductive Technology (ART) Program (clinicaltrials.gov) - Oct 27, 2013
P3, N=200, Recruiting, Sponsor: Ferring Pharmaceuticals
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- |||| VivaGel (astodrimer vaginal) / Starpharma
Trial completion: Dose-ranging Study of SPL7013 Gel for the Prevention of Bacterial Vaginosis (BV) (clinicaltrials.gov) - Oct 26, 2013
P2, N=205, Completed, Sponsor: Starpharma Pty Ltd
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- Trial suspension: Phase I Pilot Study to Evaluate the Prognostic Value of Perfusion CT for Primary Cervical Cancer (clinicaltrials.gov) - Oct 24, 2013
P1, N=20, Suspended, Sponsor: Stanford University
Active, not recruiting --> Completed Recruiting --> Suspended
- Trial termination: The ELEGANT Trial: Elevate Transvaginal Mesh vs. Anterior Colporrhaphy (clinicaltrials.gov) - Oct 22, 2013
P4, N=4, Terminated, Sponsor: Emanuel Trabuco
Recruiting --> Suspended Active, not recruiting --> Terminated; Early termination of study due to changes in funding.
- Enrollment change: The ELEGANT Trial: Elevate Transvaginal Mesh vs. Anterior Colporrhaphy (clinicaltrials.gov) - Oct 22, 2013
P4, N=4, Terminated, Sponsor: Emanuel Trabuco
Active, not recruiting --> Terminated; Early termination of study due to changes in funding. N=214 --> 4
- Trial completion, MRI: Motion Correction in Dynamic Contrast Enhanced Magnetic Resonance Imaging (MRI) in Ovarian Cancer: A Pilot Study (clinicaltrials.gov) - Oct 22, 2013
P=N/A, N=2, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
N=214 --> 4 Active, not recruiting --> Completed
- Trial withdrawal: Prospective Evaluation of Intrafractional and Interfractional Cervical Motion During External Beam Radiation for Intact Cervical Cancer by the Calypso® 4D Localization System™ (clinicaltrials.gov) - Oct 22, 2013
P=N/A, N=0, Withdrawn, Sponsor: Emory University
Active, not recruiting --> Completed Recruiting --> Withdrawn
- | carotuximab IV (ENV-105) / Kairos Pharma
Enrollment change: Evaluation of TRC105 in the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma (clinicaltrials.gov) - Oct 22, 2013
P2, N=23, Completed, Sponsor: Tracon Pharmaceuticals Inc.
Recruiting --> Withdrawn N=45 --> 23
- Enrollment change: Prospective Evaluation of Intrafractional and Interfractional Cervical Motion During External Beam Radiation for Intact Cervical Cancer by the Calypso® 4D Localization System™ (clinicaltrials.gov) - Oct 22, 2013
P=N/A, N=0, Withdrawn, Sponsor: Emory University
N=45 --> 23 N=10 --> 0
- |||||| Bravelle (urofollitropin) / Ferring
Enrollment open, Head-to-Head: Evaluation of Efficacy and Safety of Highly Purified Urofollitropin for Ovulation Induction in Chinese Females (clinicaltrials.gov) - Oct 22, 2013
P3, N=180, Recruiting, Sponsor: Ferring Pharmaceuticals
N=10 --> 0 Not yet recruiting --> Recruiting
- Trial completion: Assessing Women's Attitudes About the Risk of Infertility Related to Adjuvant Therapy for Early Breast Cancer (clinicaltrials.gov) - Oct 22, 2013
P=N/A, N=385, Completed, Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- Nexplanon (etonogestrel implant) / Organon
New P2 trial: Does Concomitant Use of Combined Oral Hormonal Steroids Stop Bleeding in Women Using Etonogestrel Implants (Implanon/Nexplanon®)?: A Randomized Controlled Study (clinicaltrials.gov) - Oct 21, 2013
P2, N=32, Recruiting, Sponsor: University of Colorado, Denver
- Enrollment change, Metastases: DBGT-OC-CR: Green Tea Intake for the Maintenance of Complete Remission in Women With Advanced Ovarian Carcinoma (clinicaltrials.gov) - Oct 21, 2013
P2, N=16, Completed, Sponsor: Centre Hospitalier Universitaire de Qu
Active, not recruiting --> Completed N=46 --> 16
- Trial completion, Metastases: DBGT-OC-CR: Green Tea Intake for the Maintenance of Complete Remission in Women With Advanced Ovarian Carcinoma (clinicaltrials.gov) - Oct 21, 2013
P2, N=16, Completed, Sponsor: Centre Hospitalier Universitaire de Qu
N=46 --> 16 Active, not recruiting --> Completed
- diphenhydramine / Generic mfg.
Enrollment open: Effects of Intravenous Lidocaine on Endometriosis Pain (clinicaltrials.gov) - Oct 20, 2013
P=N/A, N=30, Recruiting, Sponsor: Brigham and Women's Hospital
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- ||| Enrollment open: Evaluation of the Goldstein SonoBiopsy™ Catheter for Diagnosing Endometrial Pathology (clinicaltrials.gov) - Oct 20, 2013
P=N/A, N=80, Recruiting, Sponsor: Cook
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- Trial completion: Faith Moves Mountains: A Community Based Participatory Research (CBPR) Appalachian Wellness & Cancer Prevention Program (clinicaltrials.gov) - Oct 20, 2013
P=N/A, N=1415, Completed, Sponsor: Nancy Schoenberg
Not yet recruiting --> Recruiting Enrolling by invitation --> Completed
- | clomifene citrate / Generic mfg.
New P4 trial: Effect of Progestin-Induced Withdrawal Bleed on Ovulation Induction Cycles With Clomiphene Citrate (clinicaltrials.gov) - Oct 17, 2013
P4, N=154, Recruiting, Sponsor: University of British Columbia
- | exemestane / Generic mfg.
New P2 trial, Metastases: Exemestane in Advanced and Recurrent Endometrial Carcinoma (clinicaltrials.gov) - Oct 16, 2013
P2, N=52, Completed, Sponsor: Nordic Society for Gynaecologic Oncology